Sony Pixel Power calrec Sony

November 12, 2021

12/11/2021

From soapsuds to gold: Chemists develop powerful method for transforming simple, cheap chemicals into complex and valuable ones New method for desaturating aliphatic acids overcomes a long-standing challenge in synthetic chemistry.

November 12, 2021

LA JOLLA, CA Chemists at Scripps Research have solved a long-standing problem in synthetic chemistry by devising a set of reactions for transforming simple, cheap, and ubiquitous organic compounds called aliphatic acids a very broad family that ranges from detergents to vegetable oils into much more complex and valuable compounds.

The new reactions, described in a paper this week in Science, should have a broad utility for molecule-building, making chemists' tasks easier and potentially making chemical products cheaper and easier to develop across multiple industries. This includes the pharmaceutical industry, which is already beginning to use the new reactions for discovering new drugs.

These reactions are going to be general tools for making complex molecules, and because they use simple molecular oxygen to drive their catalytic cycles they can potentially be applied to large-scale manufacturing, says Jin-Quan Yu, PhD, professor of chemistry at Scripps Research, who led the study.

Aliphatic acids include chain-like arrangements of carbon atoms covered with hydrogen atoms. In most simple aliphatic acids, this chain of carbon atoms is linked together by unreactive single bonds. The new reactions enable chemists essentially to convert a selected one of these single bonds to a reactive and versatile double bond often a key step for installing polar groups in improving a compound's pharmacological properties and to do so much more quickly and easily than ever before. The double bond itself does not improve pharmacological properties, but this can be accomplished through further reactions to install polar groups.

Double bonds can then be converted to diverse structures using many other well-known reactions, including those invented by my colleagues at Scripps Research, Yu says.

The researchers also found that by tuning the structures of the catalysts that assist the dehydrogenation reaction, the newly formed double bond can further react with an alkyne partner in a cascade that yields complex bioactive compounds called lactones.

Humans and other organisms have evolved enzymes that accomplish the single-to-double bond-conversion process efficiently and effortlessly in specific contexts, for example in converting fatty acids into cellular fuel. But until now synthetic chemists haven't had a relatively simple and broad method of doing so via laboratory chemical reactions.

The new reactions use a palladium catalyst to perform the crucial first step of removing a hydrogen atom from the targeted carbon on an aliphatic acid, thus effectively freeing up electrons to form the new double bond. The key to the reactivity of the palladium catalyst is a rationally designed helper molecule a ligand called a pyridine-pyridone, which holds the palladium in a way that promotes the hydrogen removal. Yu and his team designed the pyridine-pyridone to have the precise geometry needed to carry out this task on the starting aliphatic acid without also removing hydrogen atoms from the product compound as it is formed.

The Yu lab's many innovations in synthetic chemistry over the past two decades have attracted the interest of the pharmaceutical industry, and the new work was partly funded by Bristol Myers Squibb which is currently investigating how to apply this new reaction to synthesize potential new drug compounds, Yu says.

Ligand-controlled divergent dehydrogenative reactions of carboxylic acids via C H activation was co-authored by first authors Zhen Wang and Liang Hu, and by Nikita Chekshin, Zhe Zhuang, Shaoqun Qian, Jennifer Qiao, and Jin-Quan Yu, all of Scripps Research.

The work was funded by the National Institutes of Health (2R01GM084019) and Bristol Myers Squibb.

Chemistry Yu, Jin-Quan
LINK: https://www.scripps.edu/news-and-events/press-room/2021/20211112-yu-al...
See more stories from scripps

More from Scripps

12/04/2024

April 11, 2024

Scripps Research chemists devise easier new method for making a common type of building block for drugs Scientists transform simple linear amines into saturated...

06/04/2024

April 05, 2024

A simple, inexpensive way to make carbon atoms bind together A Scripps Research team uncovers a cost-effective method for producing quaternary carbon molecules,...

04/04/2024

April 03, 2024

Developing a vaccine for the zombie drug xylazine Scripps Research chemical biologists design an early proof-of-concept vaccine that could lead to the first...

30/03/2024

March 29, 2024

How blocking a neural receptor responsible for addiction could reduce alcohol use A Scripps Research team found that a new therapeutic that targets the kappa op...

13/03/2024

March 13, 2024

New computational strategy boosts the ability of drug designers to target proteins inside the membrane Customized-design approach could streamline the design of...

29/02/2024

February 29, 2024

Scripps Research scientists reveal how first cells could have formed on Earth New phospholipid discovery brings researchers closer to understanding how primordi...

29/02/2024

February 28, 2024

How molecular handedness emerged in early biology Scripps Research chemists fill a major gap in origin-of-life theories. February 28, 2024 LA JOLLA, CA Mole...

22/02/2024

February 21, 2024

Snaking toward a universal antivenom Scripps Research scientists discovered antibodies that protect against a host of lethal snake venoms. February 21, 2024 ...

06/02/2024

February 06, 2024

Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases AbbVie...

26/01/2024

January 25, 2024

Re-energizing mitochondria to treat Alzheimer's disease Scripps Research team restored neuron-to-neuron connections in human cells. January 25, 2024 LA JO...

24/01/2024

January 04, 2024

100 years of Science Changing Life: Scripps Research celebrates a century of transforming human health For the last century, institute leaders and renowned scie...

23/01/2024

January 23, 2024

New technology lets researchers track brain cells' off switches The method could shed light on what goes awry in numerous brain conditions when neurons ar...

09/01/2024

January 08, 2024

Three decades of giving: Announcing the Calibr-Skaggs Institute for Innovative Medicines The ALSAM Foundation, founded by the Skaggs family, provides lasting g...

04/01/2024

January 03, 2024

Life science entrepreneur Gene Lay joins Scripps Research Board of Directors Lay, founder of the global biotech company BioLegend, brings invaluable experience ...

21/12/2023

December 20, 2023

Taming a plant-derived toxin Scripps Research team modifies the traditional poison picrotoxinin for potential neurological drugs and anti-parasite treatments. ...

19/12/2023

December 18, 2023

Scripps Research Executive Vice President Eric Topol gives TED talk on transformative power of AI in medicine Topol provides an overview of how AI models can i...

13/12/2023

December 12, 2023

New AI-powered algorithm could better assess people's risk of common heart condition Early detection of atrial fibrillation can reduce the risk of stroke an...

07/12/2023

December 06, 2023

Nanoparticle flu vaccine design shows promise in early tests Scripps Research-designed vaccine could provide broad, enduring protection against influenza A str...

16/11/2023

November 15, 2023

Numerous Scripps Research scientists named Highly Cited Researchers Clarivate's annual, global list represents researchers who have demonstrated significant...

07/11/2023

November 06, 2023

Multiple sclerosis drug invented at Scripps Research slows long-term devastating disease progression Late-breaking data reinforces the effectiveness and safety ...

05/10/2023

October 04, 2023

Keren Lasker named a 2023 Moore Inventor Fellow The prestigious award will support Lasker's inventive research in membraneless organelles and their applica...

22/09/2023

September 21, 2023

Michael Bollong named a 2023 Amgen Young Investigator The prestigious award will support Bollong's research identifying new molecular targets and therapeuti...

09/09/2023

September 08, 2023

Philip Dawson receives 2024 American Chemical Society National Award Dawson is honored with the Arthur C. Cope Late Careers Scholar Award for his foundational c...

07/09/2023

September 06, 2023

Scripps Research chemists devise a method for C-H activation of alcohols The method represents a new toolkit for making drugs and other compounds. September 06...

31/08/2023

August 30, 2023

Scripps Research receives $1.5M to surveil infectious disease threats in wastewater Bill & Melinda Gates Foundation award to support the development of multi-pa...

16/08/2023

August 16, 2023

How cold temperatures trigger the brain to boost appetite Scripps Research scientists' discovery could lead to new weight loss and metabolic health treatmen...

08/08/2023

August 07, 2023

Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study Scripps Research-developed antibody therapy...

04/08/2023

August 03, 2023

How sensory neurons impact the gut Scripps Research scientists show that the receptor PIEZO2 in sensory neurons controls gut motility and transit time, which a...

26/07/2023

July 26, 2023

AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets The expanded strategic collaboration will advan...

23/07/2023

July 21, 2023

Scripps Research scientists develop AI-based tracking and early-warning system for viral pandemics Machine-learning system effectively predicts emergence of pro...

19/07/2023

July 19, 2023

Monitoring T cells may allow prevention of type 1 diabetes Scripps Research study shows that analyzing T cells in blood samples could be used to select at-risk ...

19/07/2023

July 18, 2023

Scripps Research mourns passing of leading organic chemist Albert Eschenmoser Eschenmoser pioneered key reactions in synthetic chemistry and shaped the understa...

15/06/2023

June 14, 2023

Scripps Research awarded $46.8 million by NIH to promote human health through innovative translational science and training The Translational Institute is harne...

13/06/2023

June 13, 2023

Scripps Research's Danielle Grotjahn named 2023 Pew Scholar in the Biomedical Sciences The award will support Grotjahn's study of how cells assemble the...

31/05/2023

May 31, 2023

Crossing the ring: new method enables C-H activation across saturated carbocycles Scripps Research chemists add another powerful tool to their molecular editin...

24/05/2023

May 23, 2023

Scripps Research develops behind-the-scenes tool for better biomedical data discovery The new resource makes datasets more discoverable for life science communi...

19/05/2023

May 15, 2023

Scripps Research neuroscientist Hollis Cline elected to American Academy of Arts and Sciences Cline is recognized for her discoveries about the role of sensory ...

19/05/2023

May 18, 2023

Scripps Research's Skaggs Graduate School awards doctoral degrees to 31st graduating class Commencement ceremony will be livestreamed via Zoom and on instit...

13/05/2023

May 12, 2023

A better route to benzocyclobutenes, sought-after building blocks for drugs Scripps Research chemists devise a new, C-H activation-based method for the synthesi...

09/05/2023

May 08, 2023

Renowned Scripps Research professor Jeffery Kelly elected to National Academy of Sciences Kelly's groundbreaking work on protein misfolding has led to thera...

28/04/2023

April 27, 2023

Mirror-image molecules pave new path for cancer drug discovery By comparing how mirror image versions of small molecules impact clusters of proteins, Scripps R...

22/04/2023

April 21, 2023

How alcohol consumption contributes to chronic pain A Scripps Research team showed how both alcohol intake and alcohol withdrawal can lead to increased pain and...

21/04/2023

April 20, 2023

Xin Jin receives dual awards to study autism risk genes in neurodevelopment Major grants from the National Institutes of Health and California Institute for Reg...

20/04/2023

April 19, 2023

Trim the sugar: New HIV vaccine design improves immune response Scripps Research vaccine candidate headed for clinical trials. April 19, 2023 LA JOLLA, CA A...

18/04/2023

April 17, 2023

Therapeutic can seek and destroy potent opioid to treat overdoses Scripps Research chemists developed a new biologic to work against the synthetic opioid carfen...

07/03/2023

March 06, 2023

How heavy alcohol consumption increases brain inflammation The findings by a Scripps Research team point toward a potential new drug target for treating alcohol...

02/03/2023

March 01, 2023

Scientists find human antibodies that can block multiple coronaviruses including SARS-CoV-2 Results from a Scripps Research and UNC team pave the way for a vacc...

28/02/2023

February 28, 2023

$10 million grant funds Scripps Research Alcohol Research Center through its 50th year The five-year grant supports research into the neurobiology of alcohol us...

28/02/2023

February 27, 2023

Immune system drug shows promise in treating alcohol use disorder, a Scripps Research clinical trial reports Scientists at Scripps Research found that apremilas...

23/02/2023

February 16, 2023

Chemically poisoned protein acts as a molecular switch to spur cancer formation The discovery triggered development of a new potential drug to eliminate tumor...